Opportunistic Infections Citation List:
January 21 - February 3, 2011
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. The Antibiotic Monensin Causes Cell Cycle Disruption of Toxoplasma gondii Mediated through the DNA Repair Enzyme TgMSH-1. Lavine, M.D. and G. Arrizabalaga. Antimicrobial Agents and Chemotherapy, 2011. 55(2): p. 745-755; PMID[21098240].
[Pubmed]. OI_0119-020211.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
2. Multi-laboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Chaturvedi, V., R. Ramani, D. Andes, D.J. Diekema, M.A. Pfaller, M.A. Ghannoum, C. Knapp, S.R. Lockhart, L. Ostrosky-Zeichner, T.J. Walsh, K. Marchillo, S. Messer, A.R. Welshenbaugh, C. Bastulli, N. Iqbal, V.L. Paetznick, J. Rodriguez, and T. Sein. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]. PMID[21282457].
[Pubmed]. OI_0119-020211.
3. Synthesis of 2-Mercaptobenzimidazole Derivatives as Potential Anti-microbial and Cytotoxic Agents. Hosamani, K.M. and R.V. Shingalapur. Archiv Der Pharmazie, 2011. [Epub ahead of print]. PMID[21280103].
[Pubmed]. OI_0119-020211.
4. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. Wei, G.X., X. Xu, and C.D. Wu. Archives of Oral Biology, 2011. [Epub ahead of print]. PMID[21272859]. [Pubmed]. OI_0119-020211.
5. Low-level efficacy of cosmetic preservatives. Lundov, M.D., J.D. Johansen, C. Zachariae, and L. Moesby. International Journal of Cosmetic Science, 2011. [Epub ahead of print]. PMID[21272037].
[Pubmed]. OI_0119-020211.
6. Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae). Kuete, V., J. Kamga, L.P. Sandjo, B. Ngameni, H.M. Poumale, P. Ambassa, and B.T. Ngadjui. BMC Complementary and Alternative Medicine, 2011. 11(1): p. 6; PMID[21269424].
[Pubmed]. OI_0119-020211.
7. Plant production of anti-beta-glucan antibodies for immunotherapy of fungal infections in humans. Capodicasa, C., P. Chiani, C. Bromuro, F. De Bernardis, M. Catellani, A.S. Palma, Y. Liu, T. Feizi, A. Cassone, E. Benvenuto, and A. Torosantucci. Plant Biotechnology Journal, 2011. [Epub ahead of print]. PMID[21265996].
[Pubmed]. OI_0119-020211.
8. Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin B. Ishida, K., G. Visbal, J.C. Rodrigues, J.A. Urbina, W. de Souza, and S. Rozental. Journal of Infection and Chemotherapy, 2011. [Epub ahead of print]. PMID[21264486].
[Pubmed]. OI_0119-020211.
9. Antimicrobial Evaluation of the Polyisoprenylated Benzophenones Nemorosone and Guttiferone A. Monzote, L., O. Cuesta-Rubio, A. Matheeussen, T. Van Assche, L. Maes, and P. Cos. Phytotherapy Research, 2011. [Epub ahead of print]. PMID[21259352].
[Pubmed]. OI_0119-020211.
10. A Novel Cationic Ribonuclease with Antimicrobial Activity from Rana dybowskii. Tao, F., M. Fan, W. Zhao, Q. Lin, and R. Ma. Biochemical Genetics, 2011. [Epub ahead of print]. PMID[21259045].
[Pubmed]. OI_0119-020211.
11. Antifungal Properties of Crude Extracts of Five Egyptian Medicinal Plants Against Dermatophytes and Emerging Fungi. Hashem, M. Mycopathologia, 2011. [Epub ahead of print]. PMID[21258865].
[Pubmed]. OI_0119-020211.
12. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-l-lysine. Zhou, C., P. Li, X. Qi, A.R. Sharif, Y.F. Poon, Y. Cao, M.W. Chang, S.S. Leong, and M.B. Chan-Park. Biomaterials, 2011. [Epub ahead of print]. PMID[21257199].
[Pubmed]. OI_0119-020211.
13. Interactions between various microbes and ginseng botanicals. Tournas, V.H., J.S. Kohn, and E.J. Katsoudas. Critical Reviews in Microbiology, 2011. [Epub ahead of print]. PMID[21254831].
[Pubmed]. OI_0119-020211.
14. Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis. Ishida, K., J. Rodrigues, S. Cammerer, J. Urbina, I. Gilbert, W. de Souza, and S. Rozental. Annals of Clinical Microbiology and Antimicrobials, 2011. 10(1): p. 3; PMID[21255433].
[Pubmed]. OI_0119-020211.
15. Effects of Ionic and Surfactant Agents on the Antimicrobial Activity of Polyhexamethylene Biguanide. Yanai, R., K. Ueda, T. Nishida, M. Toyohara, and O. Mori. Eye & Contact Lens, 2011. [Epub ahead of print]. PMID[21252684].
[Pubmed]. OI_0119-020211.
16. Synthesis of egonol derivatives and their antimicrobial activities. Emirdag-Ozturk, S., T. Karayildirim, and H. Anil. Bioorganic and Medicinal Chemistry, 2011. 19(3): p. 1179-1188; PMID[21251840].
[Pubmed]. OI_0119-020211.
17. 2-amino-nonyl-6-methoxyl-tetralin muriate (10b) against Candida albicans augments endogenous reactive oxygen species: a microarray analysis study. Liang, R., X. Yong, Y. Jiang, Y. Tan, B. Dai, S. Wang, T. Hu, X. Chen, N. Li, Z. Dong, and Y. Cao. The FEBS Journal, 2011. [Epub ahead of print]. PMID[21251230].
[Pubmed]. OI_0119-020211.
18. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Schroeder, B.O., Z. Wu, S. Nuding, S. Groscurth, M. Marcinowski, J. Beisner, J. Buchner, M. Schaller, E.F. Stange, and J. Wehkamp. Nature, 2011. 469(7330): p. 419-423; PMID[21248850].
[Pubmed]. OI_0119-020211.
19. Synthesis and structure-activity relationship of 2-thiopyrimidine-4-one analogs as antimicrobial and anticancer agents. Prachayasittikul, S., A. Worachartcheewan, C. Nantasenamat, M. Chinworrungsee, N. Sornsongkhram, S. Ruchirawat, and V. Prachayasittikul. European Journal of Medicinal Chemistry, 2011. 46(2): p. 738-742; PMID[21216051].
[Pubmed]. OI_0119-020211.
20. Synthesis and antifungal activity of furo[2,3-f]quinolin-5-ols. Ryu, C.K., Y.H. Kim, J.H. Nho, J.A. Hong, J.H. Yoon, and A. Kim. Bioorganic & Medicinal Chemistry Letters, 2011. 21(3): p. 952-955; PMID[21215618].
[Pubmed]. OI_0119-020211.
21. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Shi, Y. and C.H. Zhou. Bioorganic & Medicinal Chemistry Letters, 2011. 21(3): p. 956-960; PMID[21215620].
[Pubmed]. OI_0119-020211.
22. Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives. Sharma, M., P. Joshi, N. Kumar, S. Joshi, R.K. Rohilla, N. Roy, and D.S. Rawat. European Journal of Medicinal Chemistry, 2011. 46(2): p. 480-487; PMID[21163555].
[Pubmed]. OI_0119-020211.
23. Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives. Kumar, S., S. Bawa, S. Drabu, H. Gupta, L. Machwal, and R. Kumar. European Journal of Medicinal Chemistry, 2011. 46(2): p. 670-675; PMID[21194811].
[Pubmed]. OI_0119-020211.
24. Diverse role of microbially bioconverted product of cabbage (Brassicaoleracea) by Pseudomonassyringe pv. T1 on inhibiting Candida species. Bajpai, V.K., S.C. Kang, E. Park, W.T. Jeon, and K.H. Baek. Food and Chemical Toxicology, 2011. 49(2): p. 403-407; PMID[21093524].
[Pubmed]. OI_0119-020211.
25. Chemical composition and antioxidant and antimicrobial activities of essential oil of Allium sphaerocephalon L. subsp. sphaerocephalon (Liliaceae) inflorescences. Lazarevic, J.S., A.S. Ethordevic, B.K. Zlatkovic, N.S. Radulovic, and R.M. Palic. Journal of the Science of Food and Agriculture, 2011. 91(2): p. 322-329; PMID[20945514].
[Pubmed]. OI_0119-020211.
26. Enzymatic activity, sensitivity to antifungal drugs and Baccharis dracunculifolia essential oil by Candida strains isolated from the oral cavities of breastfeeding infants and in their mothers' mouths and nipples. Pereira, C.A., A.C. da Costa, A.K. Machado, M. Beltrame Junior, M.S. Zollner, J.C. Junqueira, and A.O. Jorge. Mycopathologia, 2011. 171(2): p. 103-109; PMID[20703942].
[Pubmed]. OI_0119-020211.
27. Lavender, tea tree and lemon oils as antimicrobials in washing liquids and soft body balms. Kunicka-Styczynska, A., M. Sikora, and D. Kalemba. International Journal of Cosmetic Science, 2011. 33(1): p. 53-61; PMID[20572887].
[Pubmed]. OI_0119-020211.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
28. A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis. Balu, S., R. Reljic, M.J. Lewis, R.J. Pleass, R. McIntosh, C. van Kooten, M. van Egmond, S. Challacombe, J.M. Woof, and J. Ivanyi. Journal of Immunology, 2011. [Epub ahead of print]. PMID[21257971].
[Pubmed]. OI_0119-020211.
29. Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives. Horita, Y., T. Takii, R. Kuroishi, T. Chiba, K. Ogawa, L. Kremer, Y. Sato, Y. Lee, T. Hasegawa, and K. Onozaki. Bioorganic and Medicinal Chemistry Letters, 2011. 21(3): p. 899-903; PMID[21232949].
[Pubmed]. OI_0119-020211.
30. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis. Jin, J., J. Zhang, N. Guo, H. Feng, L. Li, J. Liang, K. Sun, X. Wu, X. Wang, M. Liu, X. Deng, and L. Yu. Journal of Medical Microbiology, 2011. 60(Pt 2): p. 223-239; PMID[21051548].
[Pubmed]. OI_0119-020211.
31. Design, Synthesis, and Study of a Mycobactin-Artemisinin Conjugate That Has Selective and Potent Activity against Tuberculosis and Malaria. Miller, M.J., A.J. Walz, H. Zhu, C. Wu, G. Moraski, U. Mollmann, E.M. Tristani, A.L. Crumbliss, M.T. Ferdig, L. Checkley, R.L. Edwards, and H.I. Boshoff. Journal of the American Chemical Society, 2011. [Epub ahead of print]. PMID[21275374].
[Pubmed]. OI_0119-020211.
32. Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB. Pieroni, M., S.K. Tipparaju, S. Lun, Y. Song, A.W. Sturm, W.R. Bishai, and A.P. Kozikowski. ChemMedChem, 2011. 6(2): p. 334-342; PMID[21259445].
[Pubmed]. OI_0119-020211.
Citations from the ISI Web of Knowledge Listings for O.I.
33. Synthesis and Antimicrobial Screening of Pyrazolo-3-Aryl Quinazolin-4(3H)ones. Deshmukh, M.B., S. Patil, S.S. Patil, and S.D. Jadhav. Indian Journal of Pharmaceutical Sciences, 2010. 72(4): p. 500-U104; ISI[000285553200017].
[WOS]. OI_0119-020211.
34. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives. Goncalves, R.S.B., C.R. Kaiser, M.C.S. Lourenco, M.V.N. de Souza, J.L. Wardell, S. Wardell, and A.D. da Silva. European Journal of Medicinal Chemistry, 2010. 45(12): p. 6095-6100; ISI[000285485000066].
[WOS]. OI_0119-020211.
35. Antibacterial and Antifungal Potential of some Arid Zone Plants. Jain, S.C., B. Pancholi, R. Singh, and R. Jain. Indian Journal of Pharmaceutical Sciences, 2010. 72(4): p. 510-U115; ISI[000285553200020].
[WOS]. OI_0119-020211.
36. Efficient Electrochemical Synthesis, Antimicrobial and Antiinflammatory Activity of 2 amino-5-substituted-1,3,4-oxadiazole Derivatives. Kumar, S. and D.P. Srivastava. Indian Journal of Pharmaceutical Sciences, 2010. 72(4): p. 458-464; ISI[000285553200009].
[WOS]. OI_0119-020211.